83 related articles for article (PubMed ID: 11601272)
1. Effects of the configuration of a multi-epitope chimeric malaria DNA vaccine on its antigenicity to mice.
Jiang Y; Lin C; Yin B; He X; Mao Y; Dong M; Xu P; Zhang L; Liu B; Wang H
Chin Med J (Engl); 1999 Aug; 112(8):686-90. PubMed ID: 11601272
[TBL] [Abstract][Full Text] [Related]
2. A recombinant multi-epitope, multi-stage malaria vaccine candidate expressed in Escherichia coli.
Li M; Bi H; Dong W; Xu W; Li Q; Li Y
Chin Med J (Engl); 1999 Aug; 112(8):691-7. PubMed ID: 11601273
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
[TBL] [Abstract][Full Text] [Related]
4. Towards the design of heterovalent anti-malaria vaccines: a hybrid immunogen capable of eliciting immune responses to epitopes of circumsporozoite antigens from two different species of the malaria parasite, Plasmodium.
Kironde FA; Rao KV; Shah S; Kumar A; Sahoo N
Immunology; 1991 Oct; 74(2):323-8. PubMed ID: 1721043
[TBL] [Abstract][Full Text] [Related]
5. Differential antibody responses to Plasmodium falciparum-derived B-cell epitopes induced by diepitope multiple antigen peptides (MAP) containing different T-cell epitopes.
Vasconcelos NM; Siddique AB; Ahlborg N; Berzins K
Vaccine; 2004 Dec; 23(3):343-52. PubMed ID: 15530679
[TBL] [Abstract][Full Text] [Related]
6. The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides.
Partidos C; Stanley C; Steward M
Eur J Immunol; 1992 Oct; 22(10):2675-80. PubMed ID: 1382995
[TBL] [Abstract][Full Text] [Related]
7. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
Dobaño C; Doolan DL
Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
[TBL] [Abstract][Full Text] [Related]
9. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus.
Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R
J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154
[TBL] [Abstract][Full Text] [Related]
10. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
Dobaño C; Rogers WO; Gowda K; Doolan DL
Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of malaria DNA vaccines in mice and monkeys].
Zhong H; Cao C; Li P; Li JZ; Ma QJ
Yi Chuan Xue Bao; 2000; 27(2):95-100. PubMed ID: 10887674
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum.
Calvo-Calle JM; de Oliveira GA; Clavijo P; Maracic M; Tam JP; Lu YA; Nardin EH; Nussenzweig RS; Cochrane AH
J Immunol; 1993 Feb; 150(4):1403-12. PubMed ID: 7679427
[TBL] [Abstract][Full Text] [Related]
13. Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A.
Epstein JE; Charoenvit Y; Kester KE; Wang R; Newcomer R; Fitzpatrick S; Richie TL; Tornieporth N; Heppner DG; Ockenhouse C; Majam V; Holland C; Abot E; Ganeshan H; Berzins M; Jones T; Freydberg CN; Ng J; Norman J; Carucci DJ; Cohen J; Hoffman SL
Vaccine; 2004 Apr; 22(13-14):1592-603. PubMed ID: 15068840
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
15. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
[TBL] [Abstract][Full Text] [Related]
16. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
Rainczuk A; Scorza T; Spithill TW; Smooker PM
Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
[TBL] [Abstract][Full Text] [Related]
17. [Induction of protective immune responses in rhesus monkey by immunization with recombinant plasmids of polyvalent epitopes of Plasmodium falciparum using cholera toxin B as adjuvant].
Zhong H; Cao C; Li P; Zhang YH; Shi YL; Ma QJ
Yi Chuan Xue Bao; 2000; 27(11):966-71. PubMed ID: 11209690
[TBL] [Abstract][Full Text] [Related]
18. A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.
Prieur E; Gilbert SC; Schneider J; Moore AC; Sheu EG; Goonetilleke N; Robson KJ; Hill AV
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):290-5. PubMed ID: 14694197
[TBL] [Abstract][Full Text] [Related]
19. [Humoral immune response in mice to hybrid nucleic acid vaccines containing Plasmodium falciparum merozoite surface protein 1 block 17-based gene].
Miao J; Li X; Xue C; Zhen R; Liu Z; Qin E; Yu Q
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(5):302-4. PubMed ID: 12563865
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of polyepitope libraries assembled by epitope shuffling: an approach to the development of chimeric gene vaccination against malaria.
Cai QL; Wei F; Lin YH; Shao DD; Wang H
Vaccine; 2004 Nov; 23(2):267-77. PubMed ID: 15531046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
